Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Loftis

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
International Review of Neurobiology|September 2, 2014
Neuroimmune basis of methamphetamine toxicityJennifer M Loftis, Aaron Janowsky
Psychosomatics|November 5, 2003
Safety of the treatment of interferon-alpha-induced depressionJennifer M Loftis, Peter Hauser
Pharmacology & Therapeutics|May 2, 2013
Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapyJennifer M Loftis, Marilyn Huckans
Journal of Neuroscience Research|July 22, 2021
Toward a better understanding of inflammatory microvesicles in alcohol use disorderUrsula S Sandau, Jennifer M Loftis
European Journal of Pharmacology|February 4, 2014
Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamineLuke A Downey, Jennifer M Loftis
Psychosomatics|July 1, 2010
Novel treatment strategies for depression in patients with hepatitis CJennifer M Loftis, Erick H Turner
Addiction (Abingdon, England)|May 10, 2016
Sleep disturbance in substance use disorders and comorbid chronic viral infectionsJennifer M Loftis, Miranda M Lim
CNS Drugs|August 16, 2005
Interferon-alpha treatment of patients with Hepatitis C: the role of a comprehensive risk-benefit assessmentMuhamad Aly Rifai, Jennifer M Loftis, Peter Hauser
Drugs|February 3, 2006
Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and managementJennifer M Loftis, Annette M Matthews, Peter Hauser
Neurobiology of Disease|December 1, 2009
Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategiesJennifer M Loftis, Marilyn Huckans, Benjamin J Morasco
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
International Review of Neurobiology|September 2, 2014
Neuroimmune basis of methamphetamine toxicityJennifer M Loftis, Aaron Janowsky
Psychosomatics|November 5, 2003
Safety of the treatment of interferon-alpha-induced depressionJennifer M Loftis, Peter Hauser
Pharmacology & Therapeutics|May 2, 2013
Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapyJennifer M Loftis, Marilyn Huckans
Journal of Neuroscience Research|July 22, 2021
Toward a better understanding of inflammatory microvesicles in alcohol use disorderUrsula S Sandau, Jennifer M Loftis
European Journal of Pharmacology|February 4, 2014
Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamineLuke A Downey, Jennifer M Loftis
Psychosomatics|July 1, 2010
Novel treatment strategies for depression in patients with hepatitis CJennifer M Loftis, Erick H Turner
Addiction (Abingdon, England)|May 10, 2016
Sleep disturbance in substance use disorders and comorbid chronic viral infectionsJennifer M Loftis, Miranda M Lim
CNS Drugs|August 16, 2005
Interferon-alpha treatment of patients with Hepatitis C: the role of a comprehensive risk-benefit assessmentMuhamad Aly Rifai, Jennifer M Loftis, Peter Hauser
Drugs|February 3, 2006
Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and managementJennifer M Loftis, Annette M Matthews, Peter Hauser
Neurobiology of Disease|December 1, 2009
Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategiesJennifer M Loftis, Marilyn Huckans, Benjamin J Morasco
Pageof 10